Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagshealth BIO International Convention One-on-One's Sustainability ethanol Plant biotechnology renewable fuel standard economic development FDA biofuels public policy Intellectual Property BIOTECH Biotechnology Industry Health Care biotech industry healthcare biotechnology BIO Events patent
- Most Popular
Latest VideoInnovation Is... with Doug Doerfler of MaxCyte View All >